Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A kind of muscle atrophy, the technology of composition, is applied in the field of the pharmaceutical composition for the treatment of muscle atrophy and muscle atrophy, the treatment of muscle atrophy, can solve the problems such as low incidence rate, there is no patent medicine for the treatment of muscle atrophy, the price of Riluzole is high
Inactive Publication Date: 2005-12-28
HEBEI MIN SHENG MEDICAL RES INST
View PDF0 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0002] Clinically, there is no exact understanding of the etiology and pathogenesis of muscle atrophy. Therefore, there is no effective western medicine therapy that can cure or prevent the development of the disease. The imported new drug Riluzole is expensive and has unsatisfactory curative effects. Traditional Chinese medicine treats muscle atrophy, Muscle diseases such as myasthenia are collectively referred to as atrophy. Due to the extremely low incidence of the disease, there is no medicine for treating muscle atrophy.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The present invention is based on opening the meridians, activating blood circulation and removing blood stasis, removing exogenous pathogens, nourishing the spleen and kidney, and increasing the body's own immunity to balance yin and yang, and provides a pharmaceutical composition for treating muscular atrophy, which consists of the following parts by weight Decoction pieces: Astragalus 30-80g, cinnamon 8-15g, Ziheche 6-12g, Schisandra 6-15g, gooseberry beads 10-15g, antler gum 6-12g, vinegar tortoiseshell 10-15g, cornus 6-15g 1. Melt the deer horn glue with boiling water, add 200ml of water to the drug in the above ratio, heat to 120°C, pressure 1.2-1.5, keep warm for 30-40 minutes, filter out the drug solution, and fill it. In the clinical treatment of muscular atrophy, the present invention makes good use of the situation, dialectical treatment, achieves vital energy, strengthens bone and marrow, unblocks motor nerves, regulates peripheral nerves, and repairs microcirculation of necrosis, breaking through the conclusion of Western medicine that peripheral nerve necrosis is irreparable, making necrosis The muscle molecules regenerate, so as to achieve the purpose of treatment.
Description
technical field [0001] The invention relates to a pharmaceutical composition for treating muscle atrophy, belongs to the technical field of Chinese herbal medicine preparations, and is especially suitable for clinically treating muscle weakness and muscle atrophy. Background technique [0002] Clinically, there is no exact understanding of the etiology and pathogenesis of muscle atrophy. Therefore, there is no effective western medicine therapy that can cure or prevent the development of the disease. The imported new drug Riluzole is expensive and has unsatisfactory curative effects. Traditional Chinese medicine treats muscle atrophy, Muscle diseases such as myasthenia are collectively referred to as flaccidity. Due to the extremely low incidence of the disease, there is no medicine for treating muscle atrophy. Contents of the invention [0003] The purpose of the present invention is to open the meridians, promote blood circulation and remove blood stasis first, remove ex...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more